Nihon Kohden (OTCMKTS:NHNKY) Reaches New 12-Month Low – Here’s What Happened

Nihon Kohden Corporation (OTCMKTS:NHNKY) shares reached a new 52-week low during trading on Monday . The stock traded as low as $8.1225 and last traded at $8.1225, with a volume of 1158 shares traded. The stock had previously closed at $8.48.

Analyst Ratings Changes

Separately, Zacks Research raised Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, Nihon Kohden currently has a consensus rating of “Buy”.

Nihon Kohden Price Performance

The company’s fifty day moving average price is $9.26 and its 200-day moving average price is $10.18. The stock has a market cap of $1.41 billion, a price-to-earnings ratio of 14.03 and a beta of 0.40.

Nihon Kohden (OTCMKTS:NHNKY) last released its earnings results on Thursday, May 14th. The company reported $0.34 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.10. The company had revenue of $453.10 million during the quarter, compared to analysts’ expectations of $414.40 million. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.48%. On average, sell-side analysts forecast that Nihon Kohden Corporation will post 0.61 earnings per share for the current fiscal year.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.